Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1998 Dec;95(4):648–654. doi: 10.1046/j.1365-2567.1998.00635.x

C1 inhibitor removes the entire C1qr2s2 complex from anti-C1Q monoclonal antibodies with low binding affinities.

C H Chen 1, C F Lam 1, R J Boackle 1
PMCID: PMC1364365  PMID: 9893058

Abstract

Evidence is presented for a new C1 Inhibitor (C1 INH) function. C1 INH was capable of dislodging the entire C1qr2s2 complex from C1-activating substances that bound weakly to the globular heads of C1q. Two different mouse IgG1 monoclonal antibodies with different affinities for C1q globular heads were compared for their complement-activating properties in the presence of normal human serum. As expected the higher affinity monoclonal antibody (Qu) was more effective in binding C1q and causing C1-mediated C4b deposition. Unexpectedly, time responses of C1 (C1q) binding to immobilized 3C7 reached a peak then gradually decreased. However, C1q remained constantly bound to immobilized Qu. These results indicated that after C1 activation in human serum, the entire C1 complex (including C1q) was dislodged from 3C7, but not from immobilized Qu. The addition of purified C1 INH to purified C1, which had bound to immobilized 3C7, resulted in removal of C1 (C1q). Removal of the entire C1qr2s2 did not occur when C1 INH preparations were first neutralized by the addition of purified activated C1s. In summary, it is suggested that C1 INH plays a prominent role in dislodging the entire C1qr2s2 from immunoglobulin preparations which have a low binding affinity for the globular heads of C1q.

Full text

PDF
648

Images in this article

651Figure 3
on p.651

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antón L. C., Ruiz S., Barrio E., Marqués G., Sánchez A., Vivanco F. C3 binds with similar efficiency to Fab and Fc regions of IgG immune aggregates. Eur J Immunol. 1994 Mar;24(3):599–604. doi: 10.1002/eji.1830240316. [DOI] [PubMed] [Google Scholar]
  2. Arlaud G. J., Gagnon J., Villiers C. L., Colomb M. G. Molecular characterization of the catalytic domains of human complement serine protease C1r. Biochemistry. 1986 Sep 9;25(18):5177–5182. doi: 10.1021/bi00366a029. [DOI] [PubMed] [Google Scholar]
  3. Arlaud G. J., Thielens N. M., Illy C. Assembly of the C1 complex. Behring Inst Mitt. 1993 Dec;(93):189–195. [PubMed] [Google Scholar]
  4. Aulak K. S., Donaldson V. H., Coutinho M., Davis A. E., 3rd C1-inhibitor: structure/function and biologic role. Behring Inst Mitt. 1993 Dec;(93):204–213. [PubMed] [Google Scholar]
  5. Boackle R. J., Connor M. H., Vesely J. High molecular weight non-immunoglobulin salivary agglutinins (NIA) bind C1Q globular heads and have the potential to activate the first complement component. Mol Immunol. 1993 Feb;30(3):309–319. doi: 10.1016/0161-5890(93)90059-k. [DOI] [PubMed] [Google Scholar]
  6. Chen C. H., Boackle R. J. A newly discovered function for C1 inhibitor, removal of the entire C1qr2s2 complex from immobilized human IgG subclasses. Clin Immunol Immunopathol. 1998 Apr;87(1):68–74. doi: 10.1006/clin.1997.4515. [DOI] [PubMed] [Google Scholar]
  7. Chesebro B., Wehrly K. Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity. J Virol. 1988 Oct;62(10):3779–3788. doi: 10.1128/jvi.62.10.3779-3788.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chesne S., Villiers C. L., Arlaud G. J., Lacroix M. B., Colomb M. G. Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1. Biochem J. 1982 Jan 1;201(1):61–70. doi: 10.1042/bj2010061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hoekzema R., Martens M., Brouwer M. C., Hack C. E. The distortive mechanism for the activation of complement component C1 supported by studies with a monoclonal antibody against the "arms" of C1q. Mol Immunol. 1988 May;25(5):485–494. doi: 10.1016/0161-5890(88)90169-1. [DOI] [PubMed] [Google Scholar]
  10. Jiang H. X., Siegel J. N., Gewurz H. Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q. J Immunol. 1991 Apr 1;146(7):2324–2330. [PubMed] [Google Scholar]
  11. Kilchherr E., Schumaker V. N., Phillips M. L., Curtiss L. K. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q. J Immunol. 1986 Jul 1;137(1):255–262. [PubMed] [Google Scholar]
  12. Laurell A. B., Mårtensson U., Sjöholm A. G. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s. J Immunol. 1987 Dec 15;139(12):4145–4151. [PubMed] [Google Scholar]
  13. Laurell A. B., Sjöholm A. G. C1 subcomponent complexes: basic and clinical aspects. Behring Inst Mitt. 1993 Dec;(93):292–298. [PubMed] [Google Scholar]
  14. Lennick M., Brew S. A., Ingham K. C. Kinetics of interaction of C1 inhibitor with complement C1s. Biochemistry. 1986 Jul 1;25(13):3890–3898. doi: 10.1021/bi00361a023. [DOI] [PubMed] [Google Scholar]
  15. Mollnes T. E., Høgåsen K., Hoaas B. F., Michaelsen T. E., Garred P., Harboe M. Inhibition of complement-mediated red cell lysis by immunoglobulins is dependent on the IG isotype and its C1 binding properties. Scand J Immunol. 1995 May;41(5):449–456. doi: 10.1111/j.1365-3083.1995.tb03591.x. [DOI] [PubMed] [Google Scholar]
  16. Okada M., Utsumi S. Role for the third constant domain of the IgG H chain in activation of complement in the presence of C1 inhibitor. J Immunol. 1989 Jan 1;142(1):195–201. [PubMed] [Google Scholar]
  17. Ollert M. W., Kadlec J. V., David K., Petrella E. C., Bredehorst R., Vogel C. W. Antibody-mediated complement activation on nucleated cells. A quantitative analysis of the individual reaction steps. J Immunol. 1994 Sep 1;153(5):2213–2221. [PubMed] [Google Scholar]
  18. Patston P. A., Gettins P., Beechem J., Schapira M. Mechanism of serpin action: evidence that C1 inhibitor functions as a suicide substrate. Biochemistry. 1991 Sep 10;30(36):8876–8882. doi: 10.1021/bi00100a022. [DOI] [PubMed] [Google Scholar]
  19. Perkins S. J. Three-dimensional structure and molecular modelling of C1- inhibitor. Behring Inst Mitt. 1993 Dec;(93):63–80. [PubMed] [Google Scholar]
  20. Porter R. R., Reid K. B. Activation of the complement system by antibody-antigen complexes: the classical pathway. Adv Protein Chem. 1979;33:1–71. doi: 10.1016/s0065-3233(08)60458-1. [DOI] [PubMed] [Google Scholar]
  21. Schumaker V. N., Hanson D. C., Kilchherr E., Phillips M. L., Poon P. H. A molecular mechanism for the activation of the first component of complement by immune complexes. Mol Immunol. 1986 May;23(5):557–565. doi: 10.1016/0161-5890(86)90119-7. [DOI] [PubMed] [Google Scholar]
  22. Schumaker V. N., Poon P. H., Seegan G. W., Smith C. A. Semi-flexible joint in the C1q subunit of the first component of human complement. J Mol Biol. 1981 May 15;148(2):191–197. doi: 10.1016/0022-2836(81)90511-8. [DOI] [PubMed] [Google Scholar]
  23. Schumaker V. N., Zavodszky P., Poon P. H. Activation of the first component of complement. Annu Rev Immunol. 1987;5:21–42. doi: 10.1146/annurev.iy.05.040187.000321. [DOI] [PubMed] [Google Scholar]
  24. Stevens F. J. Modification of an ELISA-based procedure for affinity determination: correction necessary for use with bivalent antibody. Mol Immunol. 1987 Oct;24(10):1055–1060. doi: 10.1016/0161-5890(87)90073-3. [DOI] [PubMed] [Google Scholar]
  25. Tseng Y., Poon P. H., Zavodszky P., Schumaker V. N. Spontaneous activation of serum C1 in vitro. Role of C1 inhibitor. J Immunol. 1991 Sep 15;147(6):1884–1890. [PubMed] [Google Scholar]
  26. Ziccardi R. J. A new role for C-1-inhibitor in homeostasis: control of activation of the first component of human complement. J Immunol. 1982 Jun;128(6):2505–2508. [PubMed] [Google Scholar]
  27. Ziccardi R. J. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition. J Immunol. 1986 May 1;136(9):3378–3383. [PubMed] [Google Scholar]
  28. Ziccardi R. J., Cooper N. R. Active disassembly of the first complement component, C-1, by C-1 inactivator. J Immunol. 1979 Aug;123(2):788–792. [PubMed] [Google Scholar]
  29. Ziccardi R. J. Demonstration of the interaction of native C1 with monomeric immunoglobulins and C1 inhibitor. J Immunol. 1985 Apr;134(4):2559–2563. [PubMed] [Google Scholar]
  30. Ziccardi R. J. The role of immune complexes in the activation of the first component of human complement. J Immunol. 1984 Jan;132(1):283–288. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES